Fresenius Kabi, LLC
Lake Zurich, IL Part of Centro Medico Imbanaco De Cali S A
- UEI
- C2TRNWNQKMD6
- CAGE
- 57KZ6
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
J9TJRDC37Y89
-
Parent
J9TJRDC37Y89
- SAM.gov registration date
- Physical address
- 3 Corporate Dr, Lake Zurich, IL 60047, USA
- Website
- fresenius-kabi.com
- Founded
- 1912
- Employees
- 100K+
- Estimated annual revenue
- $10B+
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $59,308,606 |
| FY2025 | $88,687,410 |
| FY2024 | $1,632,989 |
| FY2023 | $6,841,877 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $57,687,062 | |
| 2 | Defense Logistics Agency | $1,621,544 |
Contract vehicles
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| FKA West-Ward Pharmaceuticals | Berkeley Heights, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Sagent Pharmaceuticals, Inc. | Schaumburg, IL | 325412 Pharmaceutical Preparation Manufacturing |
| Allscripts Medication Services Group | Libertyville, IL | 325412 Pharmaceutical Preparation Manufacturing |
| Pfizer Inc. | New York, NY | 325412 Pharmaceutical Preparation Manufacturing |
| Baxter Health Systems | Deerfield, IL | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Fresenius Kabi, LLC, a foreign-owned subsidiary of Centro Medico Imbanaco De Cali S.A., supplies injectable pharmaceutical products to the federal government as a prime contractor under full-and-open competition, with no set-aside designations across its recent award footprint. The company manufactures and delivers medications including doxycycline, sodium chloride, methylprednisolone, atropine, midazolam, ketorolac, furosemide, diphenhydramine, xylocaine, dexamethasone, imipenem-cilastatin, rocuronium, and ustekinumab to federal health agencies, with primary place of performance at Lake Zurich, Illinois and a manufacturing facility in Long Grove, Illinois.
Fresenius Kabi operates predominantly as a direct supplier to federal medical supply chains. The company's customer base by potential value is dominated by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 (one award, $709.8 million combined potential value), followed by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (seven awards, $239.4 million combined potential value), and the Department of Veterans Affairs National Acquisition Center (two awards, $141.7 million combined potential value). By award count, however, the Defense Logistics Agency Troop Support Medical supply chain accounts for 3,013 of 3,024 total awards (99.6%) with $51.1 million combined potential value — a stark divergence indicating high-volume, lower-dollar transactional work through DLA's indefinite-delivery contract (SPE2D020D0009) offset by large strategic awards elsewhere. Recent representative work includes a $24.4 million definitive contract from HHS ASPR for procurement of pharmaceuticals (doxycycline, sodium chloride, methylprednisolone) awarded September 30, 2026 with completion by September 29, 2027; a $7.9 million delivery order from HHS ASPR on the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB) for atropine and midazolam (July 30, 2026); and a $139.5 million single-award indefinite-delivery contract from the VA National Acquisition Center for ustekinumab syringes and vials awarded June 5, 2026, running through June 4, 2027 with four one-year option periods.
Activity has remained relatively stable year over year, ranging from 484 to 574 awards annually across 2022–2026, with combined potential value across all 3,024 awards at $1.14 billion and obligated dollars at $215.8 million (19% of potential value). Two awards totaling $32.3 million in combined potential value face ultimate completion within the next twenty-four months, marking Fresenius Kabi's primary recompete exposure window. The vendor's award footprint is concentrated in medicinal and botanical manufacturing (3,013 awards under NAICS 325412) and pharmaceutical preparation manufacturing (10 awards), with drugs and biologicals comprising 99.9% of procured services by PSC code. Fresenius Kabi competes across no set-aside vehicles — all recent work flows through unrestricted full-and-open procurements at DLA, VA, HHS-ASPR, and NIH Clinical Center, positioning the company as a direct pharmaceutical supplier to the federal medical supply chain rather than a federal IT, engineering, or professional-services contractor.
Quick answers
Is Fresenius Kabi, LLC registered in SAM.gov?
Yes. Fresenius Kabi, LLC's SAM.gov registration is active through May 20, 2027.
Which contract vehicles does Fresenius Kabi, LLC hold?
Fresenius Kabi, LLC holds a place on 1 federal contract vehicle: FSS-61-IB.
How much has Fresenius Kabi, LLC received in federal contracts?
Federal contracts obligated $88,687,410 to Fresenius Kabi, LLC in fiscal year 2025 and $156,470,883 in fiscal years 2023 through 2027.
How does Fresenius Kabi, LLC rank among federal contractors?
Fresenius Kabi, LLC ranked #5 in NAICS 325411, #7 in NAICS 325412 and #8 in NAICS 3254 in FY2025.
What is Fresenius Kabi, LLC's most recent federal award?
Fresenius Kabi, LLC's most recent federal contract award is Procurement of pharmaceuticals - doxycycline, sodium chloride, and methylprednisolone (75A50326C00007), from Office of the Assistant Secretary for Preparedness and Response, on September 30, 2026.
On GovTribe
See Fresenius Kabi, LLC's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors